secwatch.observer — SEC 8-K summary
======================================

Issuer:     Evofem Biosciences, Inc. (EVFM)
CIK:        0001618835
Form:       8-K
Filed at:   2025-04-03T23:59:59+00:00
Accession:  0001641172-25-002583
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Evofem amends PHEXXI supply agreement with Windtree; adjusts pricing, forecast, and termination rights
--------------------------------------------------------------------------------

- Purchase price set at $15 per 12-count box for first 3 years or until tech transfer costs recovered.
- Binding forecast period adjusted to 4 months; Buyer can reduce orders up to 20% within that period without penalty.
- If supply chain disruptions persist 90 days, Buyer may terminate agreement with no further liability.
- Two instances of non-conforming product in 12 months allows Buyer termination.
- Supplier's liability capped at greater of $1M or 12 months of payments, excluding certain breaches.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1618835/000164117225002583/0001641172-25-002583-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1618835/000164117225002583/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-002583

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer